The market is segmented based on , By Product Type (Saliva Collection Kits, Fluid Specific Devices, Oral Swab, Bar-Code Labels, Saliva Cryostorage Box, Others), Site Of Collection (Sub-Mandibular/Sub-Lingual Gland, Parotid Gland, Minor Salivary Gland), Application (Liver-Lung Cancer, Breast Cancer, Colon And Rectal Cancer, Prostate Cancer, Pancreatic Cancer, Oral Cancer, Thyroid Cancer, Endometrial Cancer, Kidney Cancer, Leukemia, Melanoma, Non-Hodgkin Lymphoma, Others), Age Group (Adult, Pediatric), Method of Collection (Passive Drool, Oral Swab, Others), End User (Hospitals, Diagnostic Laboratories, Oncology Speciality Clinics, Cancer Research Institutes, Others), Distribution Channel (Direct Tenders, Retail Sales, Others) – Industry Trends and Forecast to 2031.
.
The Global Cancer Spit Test Device Market size was valued at USD 552.66 USD Million in 2023.
The Global Cancer Spit Test Device Market is projected to grow at a CAGR of 9.7% during the forecast period of 2024 to 2031.
The major players operating in the market include DNA Genotek, Salimetrics, PeriRx, Color Health, SARSTEDT AG, Miraclean Technology Co., Agilent Technologies, Illumina, QIAGEN, Thermo Fisher Scientific, Abbott, BD, Biocartis, bioMérieux SA, Siemens Healthcare GmbH, F. Hoffmann La Roche Ltd, Oasis Diagnostics Corporation, Canvax.
The market report covers data from the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of the Middle East & Africa.
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.